Reata Pharmaceuticals (RETA) PT Lowered to $200 at Ladenburg Thalmann

March 2, 2021 6:48 AM EST Send to a Friend
Ladenburg Thalmann analyst Matthew Kaplan ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login